Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
| Website | http://www.apoglyx.com |
| Employees | 4 (2 on RocketReach) |
| Founded | 2015 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biomedical Research, Therapeutic Development, Sepsis Treatment, Target Validation, Drug Development, Biotechnology, Pharmaceutical Research, Novel Therapeutics, Disease Treatment, Inflammation Research, Cell Signaling, Molecular Medicine, Life Sciences, Clinical Trials, Drug Discovery |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, GSK, Bayer, AstraZeneca, Amgen, Biogen, Lilly India +38 more (view full list) |
Looking for a particular ApoGlyx employee's phone or email?
ApoGlyx Questions
Michael Rutzler is the CEO of ApoGlyx.
2 people are employed at ApoGlyx.
Top ApoGlyx Employees
-
Michael Rutzler
CEO at ApoGlyx
Kalmar County, Sweden1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
